source
- Attovia Therapeutics and Braveheart Bio announce plans for biotech IPOs amid market upswingAttovia Therapeutics and Braveheart Bio disclosed on Tuesday that they intend to go public, joining a recent wave of large biotech offerings. Attovia, which was spun out of Alamar Biosciences in 2…
- CVS Caremark settles FTC antitrust case, agreeing to favor lowest-cost insulin on formulariesCVS Caremark announced a settlement with the Federal Trade Commission that resolves the agency’s antitrust lawsuit alleging the PBM favored higher-priced insulin versions. Under the agreement, Car…